Is Behçet's disease a ‘class 1-opathy’? The role of HLA-B*51 in the pathogenesis of Behçet's disease
- 6 October 2017
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 191 (1), 11-18
- https://doi.org/10.1111/cei.13049
Abstract
The association between carriage of the human leucocyte antigen (HLA)-B*51 allele and development of Behçet's disease (BD) has been known since the early 1970s, but the exact mechanisms responsible for its role in pathogenesis remain much-debated. In an effort to explain the disease process, it has been suggested that BD constitutes one of a newly termed group of diseases, the ‘MHC-I-opathies’. Other MHC-I-opathies include ankylosing spondylitis and HLA-B*27-associated spondyloarthropathies and HLA-C*0602-associated skin psoriasis. Recent work analysing the peptidome of HLA-B*51 suggests that altered peptide presentation by HLA-B*51 is vital to the disease process. In this review, we argue that immune receptor interactions with HLA-B*51 or the HLA-B*51-peptide complex could lead to development of inflammation in BD. The evidence for CD8+ T cell involvement is weak, and based on emerging studies it seems more likely that natural killer (NK) or other cell interactions, perhaps mediated by leucocyte immunoglobulin-like receptor (LILR) or killer immunoglobulin-like receptor (KIR) receptors, are culpable in pathogenesis. HLA misfolding leading directly to inflammation is another hypothesis for BD pathogenesis that deserves greater investigation. Ultimately, greater understanding of HLA-B*51's unique role in BD will probably lead to improved development of therapeutic strategies.Funding Information
- National Institute for Health Research
This publication has 71 references indexed in Scilit:
- Polymorphisms of interleukin 6 and interleukin 10 in Egyptian people with Behcet's diseaseImmunobiology, 2014
- Behçet disease-associated MHC class I residues implicate antigen binding and regulation of cell-mediated cytotoxicityProceedings of the National Academy of Sciences of the United States of America, 2014
- FUT2: filling the gap between genes and environment in Behçet's disease?Annals Of The Rheumatic Diseases, 2013
- Gram-negative bacteria account for main differences between faecal microbiota from patients with ulcerative colitis and healthy controlsBeneficial Microbes, 2012
- Genome-wide association study identifies GIMAP as a novel susceptibility locus for Behçet's diseaseAnnals Of The Rheumatic Diseases, 2012
- A Pyrosequencing Study in Twins Shows That Gastrointestinal Microbial Profiles Vary With Inflammatory Bowel Disease PhenotypesGastroenterology, 2010
- HLA class I supertypes: a revised and updated classificationBMC Immunology, 2008
- Autoreactive CD8+ cytotoxic T lymphocytes to major histocompatibility complex class I chain–related gene A in patients with Behçet's diseaseArthritis & Rheumatism, 2004
- Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.1990
- Close Association of HLA-Bw51 With Behcet's DiseaseAmerican Journal of Ophthalmology, 1982